NCT07523243Completed
Effect of Extracorporeal Shock Wave Therapy on Spasticity and Mobility in Stroke Patients
Efficacy of Extracorporeal Shock Wave Therapy on Spasticity, Mobility, Motor Function, and Health-Related Quality of Life in Stroke Survivors: A Prospective Randomized Sham-Controlled Trial
Source: ClinicalTrials.gov · Last updated 28 Oct 2026
Brief summary (registry, in English)
This study aims to evaluate the effectiveness of extracorporeal shock wave therapy (ESWT) in individuals with lower limb spasticity following stroke. Spasticity is a common complication after stroke and can negatively affect walking ability, mobility, and quality of life. Participants will be randomly assigned to one of two groups. Both groups will receive a standard physiotherapy and rehabilitation program. In addition, the intervention group will receive ESWT applied to the lower limb muscles, while the control group will receive a sham (placebo) ESWT application. The treatment program will be conducted three times per week for four weeks. Clinical assessments will be performed at baseline, after treatment, and during follow-up. The main outcomes of the study include muscle tone (spasticity), walking performance, motor function, and quality of life. The results of this study may help improve rehabilitation strategies and provide evidence for the use of ESWT in stroke patients.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 85 (actual)
- First submitted
- 4 Apr 2026
- Start date
- 10 Apr 2026
- Primary completion date
- 30 Apr 2026
- Lead sponsor
- Istanbul Medipol University Hospital
- Diseases
- Stroke
- NCT number
- NCT07523243
What you commit to
- Study type: Interventional
- Participants enrolled: 85
- From 10 Apr 2026 to the primary completion date, 30 Apr 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe cognitive impairment preventing participation in assessments
- Orthopedic or musculoskeletal disorders affecting lower limb function (e.g., fracture, severe osteoarthritis)
- Uncontrolled cardiovascular, respiratory, or systemic disease contraindicating exercise
- Any condition judged by the investigator to interfere with participation or safety
Other
- Receipt of botulinum toxin injection in the affected lower limb within the last 3 months
- Presence of fixed joint contractures limiting range of motion
- Participation in another interventional clinical trial
Who the study is looking for
- Adults aged 18-80 years
- Diagnosed with ischemic or hemorrhagic stroke at least 3 months prior to enrollment Presence of lower extremity spasticity with a Modified Ashworth Scale (MAS) score ≥1+
- Ability to walk independently with or without assistive devices
- Ability to understand and follow instructions for exercise interventions and assessments
- Provided written informed consent
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mehmet Salih Tan Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.